Profile
QNRX VRTX ALNY REGN ARGX SGEN
Company Name Quoin Pharmaceuticals, Ltd. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $5.05M $101.65B $61.42B $57.97B $46.27B $43.15B
Employees 0.00K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Michael Myers Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
QNRX VRTX ALNY REGN ARGX SGEN
Quant Rating Score 2 4 1 4 4 3
Quant Rating Sell Buy Strong Sell Buy Buy Neutral
Trading
QNRX VRTX ALNY REGN ARGX SGEN
Last Close $8.59 $387.15 $451.725 $585.5 $734.35 $228.74
High 52 $9.73 $516.74 $482.13 $1150.19 $768 $228.74
Low 52 $0.2 $366.54 $224.58 $482.92 $519.76 $228.74
Price vs. 52 Week High -11.72 % -25.08 % -6.31 % -49.1 % -4.38 % 0 %
Price vs. 52 Week Low 4195 % 5.62 % 101.14 % 21.24 % 41.29 % 0 %
Total Return
QNRX VRTX ALNY REGN ARGX SGEN
1 Month Return 20.14 % -0.7 % -1.13 % 2.04 % 11.04 % 0 %
3 Month Return 2.29 % -13.66 % 44.64 % 14 % 36.52 % 0 %
6 Month Return 2809.89 % -24.42 % 84.91 % -11.98 % 20.15 % 0 %
9 Month Return 1427.11 % -13.49 % 89.86 % -18.07 % 17.65 % 0 %
YTD Return 1220.12 % -3.86 % 91.97 % -17.8 % 19.41 % 0 %
1 Year Return 1385.13 % -18.35 % 65.38 % -48.59 % 38.8 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
QNRX VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -3273304.2 % 11.09 % -0.43 % 4.37 % -44.32 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Profitability
QNRX VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM -25.19 % 86.11 % 83.64 % 81.98 % 65.32 % 79.1 %
Return on Assets TTM -136.54 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -210.51 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -278.95 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 99.37 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 95.96 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -12715.39 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM - 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Receivables Turnover TTM - 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 0.09 0.43 3.93 3.54 0.88 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.21 0.96
Fixed Asset Turnover TTM - 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 1.13 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -18.19 14.98 -0.12 45.13 -1.07 -2.46
Free Cash Flow Per Share TTM -18.19 13.63 -0.4 36.58 -1.09 -2.88
Cash Per Share TTM 1324.52 % 3036 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -10659.11 % 33.68 % -0.63 % 33.37 % -3.31 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 99.98 % 90.99 % 335.21 % 81.05 % 102.26 % 117.04 %
Cash Flow Coverage Ratios TTM - 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Price To Free Cash Flows Ratio TTM -0.47 29.05 -1179.18 15.08 -596.18 -81.26
Price To Operating Cash Flows Ratio TTM -0.47 26.46 -3910.39 12.33 -706.75 -93.1
Price Cash Flow Ratio TTM -0.47 26.46 -3910.39 12.33 -706.75 -93.1
Income Statement (TTM)
QNRX VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $-0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 0% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.01B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -67.17 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
QNRX VRTX ALNY REGN ARGX SGEN
Long Term Debt $0B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.01B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0.01B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0.01B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.02B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
QNRX VRTX ALNY REGN ARGX SGEN
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.38
AARD Aardvark Therapeutics, Inc. Common Stock 11.815
ABCL AbCellera Biologics Inc. 4.7335
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.685
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.3011
ABPWW 0.046281
ABSI Absci Corporation 2.6605
ABUS Arbutus Biopharma Corporation 4.39
ABVC ABVC BioPharma, Inc. 2.76
ABVX Abivax SA American Depositary Shares 83.38
ACAD ACADIA Pharmaceuticals Inc. 24.515
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.8094
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.945
ACIU AC Immune SA 2.4679
Unlock